Showing 1 - 20 results of 26 for search 'Xiaoxue Zhu', query time: 0.07s
Refine Results
-
1
The Meal Delivery Routing Problem in E-commerce Platforms under the Shared Logistics Mode by Hualing Bi, Xiaoxue Zhu, Fuqiang Lu, Min Huang
Published 2023-10-01
Article -
2
-
3
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose and Food Effect Study to Evaluate the Tolerance, Pharmacokinetics of Jaktini... by Jingrui Liu, Binhua Lv, Hewen Yin, Xiaoxue Zhu, Haijing Wei, Yanhua Ding
Published 2020-12-01
Article -
4
-
5
Standard isometric contraction has higher reliability than maximum voluntary isometric contraction for normalizing electromyography during level walking among older adults with kne... by Xiaoxue Zhu, Yaya Pang, Li Li, Wei Sun, Lijie Ding, Qipeng Song, Peixin Shen
Published 2024-02-01
Article -
6
Species Delimitation in the Genus Moschus (Ruminantia: Moschidae) and Its High-Plateau Origin. by Tao Pan, Hui Wang, Chaochao Hu, Zhonglou Sun, Xiaoxue Zhu, Tao Meng, Xiuxiang Meng, Baowei Zhang
Published 2015-01-01
Article -
7
-
8
Pharmacokinetics, safety, and immunogenicity of HLX03, an adalimumab biosimilar, compared with reference biologic in healthy Chinese male volunteers: Results of a randomized, doubl... by Hong Zhang, Min Wu, Jixuan Sun, Xiaoxue Zhu, Cuiyun Li, Yanhua Ding, Xiaodi Zhang, Katherine Chai, Xiaojiao Li
Published 2021-04-01
Article -
9
First-in-Human, Double-Blind, Randomized, Placebo-Controlled Trial of TQ-F3083, a New Dipeptidyl Peptidase-4 Inhibitor, in Healthy Chinese Adults by Jingrui Liu, Xiaoxue Zhu, Hong Zhang, Haijing Wei, Deming Yang, Zhongnan Xu, Dandan Huo, Xiaojiao Li, Yanhua Ding
Published 2021-07-01
Article -
10
A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra®) in Chinese healthy subjects by Hong Zhang, Xiaojiao Li, Jingrui Liu, Cuiyun Li, Min Wu, Xiaoxue Zhu, Jixuan Sun, Min Fang, Yanhua Ding
Published 2021-01-01
Article -
11
Safety, tolerability and pharmacokinetics of forsythin in healthy subjects: a double-blinded, placebo-controlled single-dose and multiple-dose escalation and food effect study by Cuiyun Li, Min Wu, Hong Zhang, Xiaoxue Zhu, Li Fu, Shuo Wang, Mingming Lu, Dafang Zhong, Yanhua Ding
Published 2023-12-01
Article -
12
Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid X receptor (FXR) agonist-TQA3526 in healthy Chinese volunteers: a double-blind, randomized, placebo... by Jia Xu, Hong Zhang, Hong Chen, Xiaoxue Zhu, Haiyan Jia, Zhongnan Xu, Dandan Huo, Hong Zhang, Cuiyun Li, Yanhua Ding
Published 2023-12-01
Article -
13
Isothermal amplification and rapid detection of Klebsiella pneumoniae based on the multiple cross displacement amplification (MCDA) and gold nanoparticle lateral flow biosensor (LF... by Lina Niu, Fan Zhao, Jinlong Chen, Jinqing Nong, Chunmei Wang, Jing Wang, Naishu Gao, Xiaoxue Zhu, Lei Wu, Shoukui Hu
Published 2018-01-01
Article -
14
-
15
-
16
-
17
-
18
A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects by Hong Zhang, Hong Chen, Xiaojiao Li, Min Wu, Xiaoxue Zhu, Cuiyun Li, Jingrui Liu, Haijing Wei, Yue Hu, Jingjing Wang, Yongmin Yang, Xiangyang Zhu, Yanhua Ding
Published 2021-03-01
Article -
19
A Biosimilarity Study Between QX001S and Ustekinumab in Healthy Chinese Male Subjects by Lei Gao, Qingmei Li, Hong Zhang, Min Wu, Min Fang, Lizhi Yang, Xiaojiao Li, Jingrui Liu, Cuiyun Li, Hong Chen, Xiaoxue Zhu, Yanhua Ding, Mingwei Zhou
Published 2021-05-01
Article -
20
A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men by Hong Zhang, Hong Wang, Haijing Wei, Hong Chen, Jingrui Liu, Cuiyun Li, Xiaoxue Zhu, Xiaojiao Li, Jinchen Yu, Yinbo Zhou, Xiaolei Yang, Zhaohe Wang, Min Wu, Yanhua Ding
Published 2021-01-01
Article